Pulse Biosciences (PLSE) Competitors $14.99 -0.12 (-0.79%) Closing price 04:00 PM EasternExtended Trading$15.05 +0.06 (+0.40%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock PLSE vs. TMDX, SLNO, NVST, LIVN, WRBY, INSP, LQDA, PRCT, LMAT, and AORTShould you be buying Pulse Biosciences stock or one of its competitors? The main competitors of Pulse Biosciences include TransMedics Group (TMDX), Soleno Therapeutics (SLNO), Envista (NVST), LivaNova (LIVN), Warby Parker (WRBY), Inspire Medical Systems (INSP), Liquidia Technologies (LQDA), PROCEPT BioRobotics (PRCT), LeMaitre Vascular (LMAT), and Artivion (AORT). These companies are all part of the "medical equipment" industry. Pulse Biosciences vs. Its Competitors TransMedics Group Soleno Therapeutics Envista LivaNova Warby Parker Inspire Medical Systems Liquidia Technologies PROCEPT BioRobotics LeMaitre Vascular Artivion Pulse Biosciences (NASDAQ:PLSE) and TransMedics Group (NASDAQ:TMDX) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, earnings, valuation, profitability, dividends, institutional ownership, analyst recommendations and media sentiment. Which has stronger valuation & earnings, PLSE or TMDX? TransMedics Group has higher revenue and earnings than Pulse Biosciences. Pulse Biosciences is trading at a lower price-to-earnings ratio than TransMedics Group, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPulse Biosciences$700K1,440.75-$53.58M-$1.05-14.28TransMedics Group$441.54M8.26$35.46M$1.9355.41 Is PLSE or TMDX more profitable? TransMedics Group has a net margin of 13.49% compared to Pulse Biosciences' net margin of 0.00%. TransMedics Group's return on equity of 28.02% beat Pulse Biosciences' return on equity.Company Net Margins Return on Equity Return on Assets Pulse BiosciencesN/A -63.19% -54.98% TransMedics Group 13.49%28.02%8.64% Does the media favor PLSE or TMDX? In the previous week, TransMedics Group had 13 more articles in the media than Pulse Biosciences. MarketBeat recorded 14 mentions for TransMedics Group and 1 mentions for Pulse Biosciences. Pulse Biosciences' average media sentiment score of 1.31 beat TransMedics Group's score of 1.03 indicating that Pulse Biosciences is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Pulse Biosciences 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive TransMedics Group 10 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do insiders & institutionals hold more shares of PLSE or TMDX? 77.0% of Pulse Biosciences shares are owned by institutional investors. Comparatively, 99.7% of TransMedics Group shares are owned by institutional investors. 71.5% of Pulse Biosciences shares are owned by company insiders. Comparatively, 7.0% of TransMedics Group shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Which has more risk & volatility, PLSE or TMDX? Pulse Biosciences has a beta of 1.68, suggesting that its stock price is 68% more volatile than the S&P 500. Comparatively, TransMedics Group has a beta of 2.18, suggesting that its stock price is 118% more volatile than the S&P 500. Do analysts rate PLSE or TMDX? Pulse Biosciences presently has a consensus target price of $22.00, suggesting a potential upside of 46.76%. TransMedics Group has a consensus target price of $123.00, suggesting a potential upside of 15.02%. Given Pulse Biosciences' stronger consensus rating and higher probable upside, equities research analysts plainly believe Pulse Biosciences is more favorable than TransMedics Group.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Pulse Biosciences 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00TransMedics Group 0 Sell rating(s) 3 Hold rating(s) 5 Buy rating(s) 1 Strong Buy rating(s) 2.78 SummaryTransMedics Group beats Pulse Biosciences on 12 of the 17 factors compared between the two stocks. Get Pulse Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for PLSE and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding PLSE and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PLSE vs. The Competition Export to ExcelMetricPulse BiosciencesMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.05B$7.09B$5.77B$9.77BDividend YieldN/A1.19%6.66%4.49%P/E Ratio-14.2825.2882.3726.60Price / Sales1,440.7571.05536.82175.38Price / CashN/A22.4425.7028.92Price / Book9.676.9510.646.56Net Income-$53.58M$176.68M$3.28B$266.04M7 Day Performance-5.43%-0.23%-0.08%-0.58%1 Month Performance1.63%3.72%10.36%6.24%1 Year Performance-12.34%8.22%49.00%22.21% Pulse Biosciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PLSEPulse Biosciences4.0127 of 5 stars$14.99-0.8%$22.00+46.8%-18.9%$1.05B$700K-14.28140News CoveragePositive NewsTMDXTransMedics Group3.1719 of 5 stars$114.97-4.1%$123.00+7.0%-33.6%$4.09B$531.29M59.57210Positive NewsSLNOSoleno Therapeutics4.5503 of 5 stars$66.51-3.0%$115.09+73.0%+37.3%$3.64BN/A-16.0730Positive NewsNVSTEnvista3.7846 of 5 stars$21.15-2.6%$20.92-1.1%+13.3%$3.61B$2.55B66.1012,300News CoveragePositive NewsLIVNLivaNova1.7206 of 5 stars$56.35+0.8%$59.71+6.0%+13.0%$3.05B$1.25B-14.492,900News CoveragePositive NewsAnalyst ForecastWRBYWarby Parker1.7626 of 5 stars$26.18-3.1%$24.06-8.1%+71.6%$2.84B$771.32M-373.883,780Positive NewsINSPInspire Medical Systems4.9928 of 5 stars$93.20-2.9%$165.62+77.7%-47.4%$2.84B$802.80M53.881,246Trending NewsAnalyst ForecastInsider TradeLQDALiquidia Technologies2.6436 of 5 stars$26.25-2.2%$32.11+22.3%+200.5%$2.31B$14M-15.4450Trending NewsInsider TradeOptions VolumePRCTPROCEPT BioRobotics3.6613 of 5 stars$39.31-4.7%$74.88+90.5%-49.9%$2.29B$224.50M-25.36430News CoveragePositive NewsAnalyst UpgradeLMATLeMaitre Vascular3.0674 of 5 stars$97.60-2.7%$97.60+5.2%$2.27B$219.86M47.38490Positive NewsAORTArtivion3.3052 of 5 stars$43.53-2.9%$40.63-6.7%+60.9%$2.12B$388.54M-103.641,600 Related Companies and Tools Related Companies TMDX Competitors SLNO Competitors NVST Competitors LIVN Competitors WRBY Competitors INSP Competitors LQDA Competitors PRCT Competitors LMAT Competitors AORT Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:PLSE) was last updated on 9/3/2025 by MarketBeat.com Staff From Our PartnersHow “Trump’s New Dollar” Could Impact Your WealthPresident Trump just signed a game-changing law… That could soon upgrade the U.S. dollar in your checking a...Brownstone Research | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredWhat's the Best Way to Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | SponsoredThe Orphaned Well Crisis Hidden Across AmericaAcross the U.S., millions of abandoned oil and gas wells are leaking methane into the air — a costly and dange...The Tomorrow Investor | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Coin Could Explode, and it’s Hiding in Plain Sight!The #1 coin with skyrocket potential right now... Sometimes the biggest opportunities are hiding in plain s...Crypto 101 Media | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredWarren Buffett Issues Cryptic Warning on U.S. DollarImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pulse Biosciences, Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share Pulse Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PLSE Stock Alerts